Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
archives
»
Monthly Archive
» November 2010
November 2010
Glaxo’s Avodart Faces FDA Questions on Prostate Cancer Benefits
Glaxo’s Avodart Faces FDA Questions on Prostate Cancer Benefits
Bloomberg
GSK
Avodart
prostate cancer
Ranbaxy Gains Most in 8 Weeks on Report It Will Release Aricept Copy Today
Ranbaxy Gains Most in 8 Weeks on Report It Will Release Aricept Copy Today
Bloomberg
Ranbaxy
generics
Aricept
Alzheimer's disease
Eisai
Let’s Have a Healthy Dialogue in the Drug Sector
Let’s Have a Healthy Dialogue in the Drug Sector
WSJ Online
Bayer
GSK
Novartis
Eli Lilly
JNJ
social media
AstraZeneca
twitter
Glaxo to increase Theravance shareholding
Glaxo to increase Theravance shareholding
Yahoo/AP
Theravance
GSK
Actelion Takeover: Constant Speculation, Doubts Linger
Actelion Takeover: Constant Speculation, Doubts Linger
Seeking Alpha
M&A
Abbott Laboratories
Actelion
GSK
JNJ
Roche
Amgen
Bristol-Myers Squibb
Johnson & Johnson's Intrinsic Value
Johnson & Johnson's Intrinsic Value
Seeking Alpha
JNJ
Basilea Awarded $130 Million in Johnson & Johnson Dispute
Basilea Awarded $130 Million in Johnson & Johnson Dispute
Bloomberg
JNJ
Basilea
settlements
Analysis: Pharma's woes not over, more restructuring seen
Analysis: Pharma's woes not over, more restructuring seen
Reuters India
layoffs
restructuring
Ranbaxy to launch low-cost Alzheimer drug in US soon
Ranbaxy to launch low-cost Alzheimer drug in US soon
Economic Times, India
Ranbaxy
Aricept
Eisai
Pfizer
Bad blood grows between Roche, Novartis CEOs
Bad blood grows between Roche, Novartis CEOs
Sify, India
Roche
Novartis
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »